{"id":396661,"date":"2020-12-09T12:23:21","date_gmt":"2020-12-09T17:23:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=396661"},"modified":"2020-12-09T12:23:21","modified_gmt":"2020-12-09T17:23:21","slug":"acelrx-pharmaceuticals-to-present-at-ld-micro-main-event","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/","title":{"rendered":"AcelRx Pharmaceuticals to Present at LD Micro Main Event"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n REDWOOD CITY, Calif.<\/span>, Dec.\u00a09, 2020 \/PRNewswire\/ —\u00a0AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be providing an overview of the business and company updates at the LD Micro Main Event to be held December 14<\/span> at 1:40 p.m. ET<\/span> (10:40 a.m. PT<\/span>). A live webcast link of the event can be found on the main conference website at https:\/\/ve.mysequire.com\/<\/a>. <\/p>\n

For those not available to listen to the live webcast, a replay will be archived for 90 days and available through the conference website at https:\/\/ve.mysequire.com\/<\/a>.<\/p>\n

\n About AcelRx Pharmaceuticals, Inc.
<\/b>AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx’s proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The Company has one approved product in the U.S., DSUVIA\u00ae (sufentanil sublingual tablet, 30 mcg), known as DZUVEO in Europe<\/span>, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and one product candidate, Zalviso\u00ae(sufentanil sublingual tablet system, SST system, 15 mcg) being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings. DZUVEO and Zalviso are both approved products in Europe<\/span>. Zalviso is not approved in the U.S. For additional information about AcelRx, please visit www.acelrx.com<\/a>.<\/p>\n

\n

\n
\n \"AcelRx
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event-301189692.html<\/a><\/p>\n

SOURCE AcelRx Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire REDWOOD CITY, Calif., Dec.\u00a09, 2020 \/PRNewswire\/ —\u00a0AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be providing an overview of the business and company updates at the LD Micro Main Event to be held December 14 at 1:40 p.m. ET (10:40 a.m. PT). A live webcast link of the event can be found on the main conference website at https:\/\/ve.mysequire.com\/. For those not available to listen to the live webcast, a replay will be archived for 90 days and available through the conference website at https:\/\/ve.mysequire.com\/. About AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical … <\/p>\n

Continue reading “AcelRx Pharmaceuticals to Present at LD Micro Main Event”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-396661","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAcelRx Pharmaceuticals to Present at LD Micro Main Event - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AcelRx Pharmaceuticals to Present at LD Micro Main Event - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire REDWOOD CITY, Calif., Dec.\u00a09, 2020 \/PRNewswire\/ —\u00a0AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be providing an overview of the business and company updates at the LD Micro Main Event to be held December 14 at 1:40 p.m. ET (10:40 a.m. PT). A live webcast link of the event can be found on the main conference website at https:\/\/ve.mysequire.com\/. For those not available to listen to the live webcast, a replay will be archived for 90 days and available through the conference website at https:\/\/ve.mysequire.com\/. About AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical … Continue reading "AcelRx Pharmaceuticals to Present at LD Micro Main Event"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-09T17:23:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/10977\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AcelRx Pharmaceuticals to Present at LD Micro Main Event\",\"datePublished\":\"2020-12-09T17:23:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/\"},\"wordCount\":281,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/10977\\\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/\",\"name\":\"AcelRx Pharmaceuticals to Present at LD Micro Main Event - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/10977\\\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg\",\"datePublished\":\"2020-12-09T17:23:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/10977\\\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/10977\\\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AcelRx Pharmaceuticals to Present at LD Micro Main Event\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AcelRx Pharmaceuticals to Present at LD Micro Main Event - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/","og_locale":"en_US","og_type":"article","og_title":"AcelRx Pharmaceuticals to Present at LD Micro Main Event - Market Newsdesk","og_description":"PR Newswire REDWOOD CITY, Calif., Dec.\u00a09, 2020 \/PRNewswire\/ —\u00a0AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in medically supervised settings, today announced that management will be providing an overview of the business and company updates at the LD Micro Main Event to be held December 14 at 1:40 p.m. ET (10:40 a.m. PT). A live webcast link of the event can be found on the main conference website at https:\/\/ve.mysequire.com\/. For those not available to listen to the live webcast, a replay will be archived for 90 days and available through the conference website at https:\/\/ve.mysequire.com\/. About AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical … Continue reading \"AcelRx Pharmaceuticals to Present at LD Micro Main Event\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-09T17:23:21+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/10977\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AcelRx Pharmaceuticals to Present at LD Micro Main Event","datePublished":"2020-12-09T17:23:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/"},"wordCount":281,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/10977\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/","name":"AcelRx Pharmaceuticals to Present at LD Micro Main Event - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/10977\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg","datePublished":"2020-12-09T17:23:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/10977\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/10977\/acelrx_pharmaceuticals_inc_logo1838_21100jpg.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acelrx-pharmaceuticals-to-present-at-ld-micro-main-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AcelRx Pharmaceuticals to Present at LD Micro Main Event"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=396661"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396661\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=396661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=396661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=396661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}